In this article, we are going to take a look at where Tempus AI Inc. (NASDAQ:TEM) stands against the other stocks. The stock market extended its winning streak on Wednesday, closing firmer as ...

Tempus AI’s moat on its healthcare diagnostics platform ... and analytical platform has also emerged as a pivotal growth vector. While the company is still unprofitable, management has already ...

Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared to its daily average volume of about 5.67 million. All thanks to three ...

Whales with a lot of money to spend have taken a noticeably bearish stance on Tempus AI. Looking at options history for Tempus AI (NASDAQ:TEM) we detected 21 trades. If we consider the specifics ...

Tempus AI (TEM) is soaring 13% today after investment bank TD Cowen reinstated coverage of the shares with a Buy rating. TEM provides next generation sequencing diagnostics, polymerase chain ...

TD Cowen analyst Dan Brennan reinstated coverage of Tempus AI (TEM) with a Buy rating and price target of $74, up from $58, following the closed of the Ambry acquisition. The deal affords Tempus ...

Tempus AI has delivered an 82% YTD return, outperforming the broader market and AI-themed stocks amidst market volatility. A couple of days back, TEM closed the acquisition of Ambry Genetics ...

Ryan M. Bartolucci, Chief Accounting Officer at Tempus AI , Inc. (NASDAQ:TEM), recently sold a significant portion of company stock, according to a recent SEC filing. On February 5, Bartolucci ...

We recently published a list of Top 10 AI Stocks Trending On Wall Street. In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands against other top AI stocks ...

In a regulatory filing, Tempus AI (TEM) disclosed that COO Ryan Fukushima sold 20,000 shares of the company’s stock. The stock was sold at an average price of $62.50, for a total value of $1.2M.